Ellen Zane, Director at Parexel, holds 32.23K shares in Synchrony Financial (Ticker: SYF), holds 27.93K shares in Boston Scientific (Ticker: BSX), holds 19.37K shares in Haemonetics (Ticker: HAE).
Ellen Zane latest transaction was an Uninformative Buy of $60.00K.
What was Ellen Zane's most profitable transaction?
Ellen Zane’s most profitable transaction was an Informative Sell of PRXL stock on February 21, 2013. The return on the trade was -58.20%.
What is Ellen Zane's role in Parexel?
Ellen Zane's role in Parexel is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.